Skip to main content
    N

    Neuroone Medical Technologies Corp (NMTC)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.74
    -0.00 (-0.01%)

    Market Cap: $6.78M

    Last updated: Nov 17, 2026 at 11:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    52%(11/21)
    Avg Surprise
    +13.66%

    Upcoming Estimates

    Reports Dec 15, 2026 after closePeriod ending Sep 30, 2026
    EPS Consensus-$0.20
    Range-$0.20 - -$0.20
    5 analysts
    Revenue Consensus
    $3.27M
    Range$2.59M - $3.99M
    5 analysts
    Reports Feb 15, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.17
    Range-$0.22 - -$0.14
    3 analysts
    EPS Revisions
    0
    2
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.15-15.9%
    60d ago-$0.15-15.9%
    30d ago-$0.170.0%
    7d ago-$0.170.0%
    Current-$0.17
    Revenue Consensus
    $3.07M
    Range$3.05M - $3.10M
    2 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-0.91xFCF Yield-109.99%
    Profitability
    Profit Margin-59.70%Operating Margin-63.40%
    ROE-124.70%ROIC-147.05%
    Financial Health
    Debt/Equity0.02xInterest CoverageN/A
    Current Ratio2.84xQuick Ratio1.71x
    Trading Statistics
    Beta0.90Avg Volume63.73K
    52-Week High$6.1252-Week Low$0.74

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 32.4% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 33.0, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$0.84
    SMA 20$0.88
    SMA 50$1.10
    SMA 200$2.96
    EMA 10$0.82
    EMA 20$0.88
    EMA 50$1.15
    EMA 200$2.51

    MACD

    Line: -0.10Signal: -0.10Hist: -0.00

    ADX

    ADX: 9.1+DI: 19.1-DI: 19.2

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down100.0
    PSAR$0.98

    Bollinger Bands

    Upper Band$1.04
    Lower Band$0.71
    %B Position3768%(Upper)
    Band Width0.10

    RSI (14-Day)

    Neutral
    33.0

    Momentum Oscillators

    Stoch %K0.3
    Stoch %D5.3
    Williams %R-100.0
    ROC (10d)-20.3%
    Momentum-0.19
    CCI (20d)-125.6
    MFI (14d)46.7

    Volatility Measures

    ATR (14d)$0.10(13.7%)
    StdDev (20d)0.08
    Hist Vol105.1%(High)

    Volume Flow

    VWAP$0.77
    OBV-11.9M
    AD Line8.0B
    CMF (20d)-0.220

    Volume Metrics

    Avg Vol (20d)66.1K
    Vol Ratio0.4x(Low)
    VWMA (20d)$0.91

    Pivot Points

    R3$0.79
    R2$0.78
    R1$0.76
    Pivot Point$0.75
    S1$0.74
    S2$0.73
    S3$0.71

    Advanced Oscillators

    TSI-28.63
    Ultimate Osc31.7
    KST-227.23

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about NMTC

    News

    NMTC Valuation

    GNG's valuation label for NMTC is Undervalued.

    P/FCF
    -0.9x
    P/B
    1.7x
    All NMTC metrics

    NMTC Profitability: Margins, ROIC and FCF

    Neuroone Medical Technologies (NMTC) has a gross margin of 55.7%, an operating margin of -63.4% and a net margin of -59.7%. It posts -147.0% ROIC and a -71.6% FCF margin.

    Gross margin
    55.7%
    Operating margin
    -63.4%
    Net margin
    -59.7%
    ROIC
    -147.0%
    ROE
    -124.7%
    FCF margin
    -71.6%
    FCF yield
    -110.0%
    NMTC financial statements

    Neuroone Medical Technologies Competitors

    The companies most similar to Neuroone Medical Technologies (NMTC) include WORK Medical Technology Group LTD Ordinary Shares, Trinity Biotech and Nuwellis.

    Sector: Healthcare

    Companies most similar to Neuroone Medical Technologies

    NMTC Analyst Ratings

    Neuroone Medical Technologies (NMTC) has a Buy consensus from 3 analysts: 3 Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell.

    Consensus
    Buy
    Analysts
    3
    Strong Buy
    1
    Buy
    2
    Hold
    0
    Sell
    0
    Strong Sell
    0
    NMTC stock forecast

    NMTC Bull Case vs Bear Case

    Bull case

    • NMTC grew quarterly revenue 16.3% year over year.

    Bear case

    • NMTC has a -59.7% net profit margin.

    NMTC Earnings: Beat Rate and Next Report

    Neuroone Medical Technologies (NMTC) beat the EPS estimate in 5 of the last 8 quarters (62.5%). Its next report is confirmed on Dec 15, 2026.

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    29.1%
    EPS estimate (fiscal period ending Sep 30, 2026)
    -$0.20
    NMTC earnings history

    NMTC Earnings Date

    NMTC reports Dec 15, 2026, after the close. The date is confirmed.

    NMTC Earnings Call

    The latest NMTC earnings call transcript on file is labeled 2026Q2.

    Read the 2026Q2 transcript

    NMTC ETF Holders

    See insider activity

    Updated Aug 15, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About NMTC

    When does NMTC report earnings?

    Neuroone Medical Technologies Corp (NMTC) is confirmed to report earnings on Dec 15, 2026.

    Does NMTC pay dividends?

    Neuroone Medical Technologies Corp (NMTC) does not currently pay a regular dividend.

    What is NMTC's market cap?

    Neuroone Medical Technologies Corp (NMTC) has a market capitalization of $6.78M with a current stock price of $0.74.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.